Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α
Authors:
Open Access
- 22 December 2020
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 51 (4) , 978-988
Abstract
Icaritin, a small molecule currently being investigated in phase III clinical trials in China (NCT03236636 and NCT03236649) for treatment of advanced hepatocellular carcinoma (HCC), is a prenylflavonoid derivative obtained from the Epimedium genus. Previously, it was found that Icaritin decreased the expression of PD‐L1, but its direct molecular targets and the underlying mechanisms have not been identified. In this study, we report the identification of IKK‐α as the protein target of Icaritin by biotin‐based affinity binding assay. The further mutagenesis assay has provided evidence that C46 and C178 in IKK‐α were essential amino acids for Icaritin binding to IKK‐α, revealing the binding sites of Icaritin to IKK‐α for the first time. Functionally, Icaritin inhibited the NF‐κB signalling pathway by blocking IKK complex formation, which led to decreased nuclear translocation of NF‐κB p65, and subsequent downregulation of PD‐L1 expression in a dose–dependent manner. More importantly, PD‐L1‐positive patients exhibited longer overall survival upon Icaritin therapy. Finally, Icaritin in combination with checkpoints antibodies, such as α‐PD‐1, has demonstrated much better efficacy than any single therapy in animal models. This is the first report that anticancer effects of Icaritin are mediated, at least in part, by impairing functions of IKK‐α.Keywords
This publication has 36 references indexed in Scilit:
- The Flavonoid Apigenin Downregulates CDK1 by Directly Targeting Ribosomal Protein S9PLOS ONE, 2013
- Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targetsProceedings of the National Academy of Sciences, 2013
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2Journal of Experimental Medicine, 2012
- A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα proteinCarcinogenesis, 2012
- Harnessing Dendritic Cells for Tumor Antigen PresentationCancers, 2011
- Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer CellsPLOS ONE, 2011
- Development of Monocytes, Macrophages, and Dendritic CellsScience, 2010
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθFEBS Letters, 2004
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999